RG
INDV icon

Renaissance Group’s Indivior Pharmaceuticals INDV Stock Holding History

Renaissance Group’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-130,529
Closed -$2.1M – 247
2024
Q2 		$2.1M Buy
130,529
+2,351
+2% +$42.4K 0.08% 192
2024
Q1 		$2.75M Buy
128,178
+25,155
+24% +$473K 0.1% 155
2023
Q4 		$1.57M Buy
103,023
+5,896
+6% +$105K 0.07% 188
2023
Q3 		$2.24M Buy
97,127
+1,959
+2% +$44.7K 0.1% 130
2023
Q2 		$2.26M Buy
+95,168
New +$2.18M 0.1% 128

Other funds holding INDV

TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.3B AUM 16.7% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return